Stanley Manne Childrens Research Institute is located in Chicago, IL. The organization was established in 1987. According to its NTEE Classification (H11) the organization is classified as: Single Organization Support, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Stanley Manne Childrens Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 08/2021, Stanley Manne Childrens Research Institute generated $39.0m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (4.5%) each year. All expenses for the organization totaled $51.0m during the year ending 08/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
STANLEY MANNE CHILDREN'S RESEARCH INSTITUTE STRIVES TO GENERATE NEW KNOWLEDGE & ADVANCE THE PREVENTION, DIAGNOSIS, AND TREATMENT OF PEDIATRIC DISEASES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE MISSION OF MANNE RESEARCH INSTITUTE IS TO GENERATE NEW KNOWLEDGE AND TRANSLATE ADVANCEMENTS IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF DISEASES THAT AFFECT CHILDREN'S HEALTH THROUGH ADOLESCENCE AND ADULTHOOD. ITS MULTIDISCIPLINARY TEAMS OF PHYSICIANS, SCIENTISTS, TECHNICIANS, NURSES AND TRAINEES ARE COMMITTED TO MAKING DISCOVERIES THAT WILL IMPROVE THE LIVES OF CHILDREN AND THEIR FAMILIES. MANNE RESEARCH INSTITUTE FACULTY MEMBERS INVESTIGATE A BROAD SPECTRUM OF CHILDREN'S HEALTH AND DISEASES ACROSS THE TRANSLATIONAL SCIENCE SPECTRUM. BASIC RESEARCHERS STUDY THE MECHANISMS UNDERLYING FUNDAMENTAL PROCESSES AND RELATED DISEASES, INCLUDING HUMAN DEVELOPMENT, GENETICS OR BRAIN CIRCUITRY. ITS TRANSLATIONAL RESEARCH CONNECTS ITS BASIC SCIENCE FINDINGS TO HUMAN MEDICINE. CLINICAL RESEARCH FOCUSES ON TREATING OR CURING DISEASES AND IMPROVING THERAPIES, PROCEDURES OR DEVICES. OTHER FACULTY MEMBERS ENGAGE IN OUTCOMES, CLINICAL IMPLEMENTATION, AND COMMUNITY AND POPULATION-BASED RESEARCH TO BENEFIT CHILDREN, THEIR FAMILIES AND THEIR COMMUNITIES. RESEARCHERS INCLUDE PHYSICIANS, LABORATORY SCIENTISTS, NURSES, CHEMISTS AND OTHERS WHO SHARE THEIR EXPERTISE. THE PEDIATRICIANS AND SCIENTISTS ROUTINELY COLLABORATE WITH LURIE CHILDREN'S ACADEMIC PARTNER, NORTHWESTERN UNIVERSITY, OTHER MEDICAL CENTERS AND ACADEMIC INSTITUTIONS ACROSS THE GLOBE, AS WELL AS WITH COMMUNITY PARTNERS SUCH AS SCHOOLS AND GOVERNMENTS. MANNE RESEARCH INSTITUTE INCLUDES MORE THAN 200 INVESTIGATORS AND MORE THAN $72M IN EXTERNAL FUNDING ANNUALLY FOR RESEARCH, TWO-THIRDS OF THAT FROM THE NATIONAL INSTITUTES OF HEALTH (NIH) AND OTHER FEDERAL AGENCIES. IT IS ONE OF THE NATION'S PREMIER INSTITUTES FOR PEDIATRIC RESEARCH, INVESTING MORE DOLLARS AND RESOURCES IN PEDIATRIC RESEARCH THAN ANY OTHER AREA HOSPITAL. THE INSTITUTE HAS APPROXIMATELY 125,000 SQUARE FEET OF STATE-OF-THE-ART LABORATORY SPACE. IN THE SUMMER OF 2019, MANNE RESEARCH INSTITUTE WET-LAB RESEARCH MOVED FROM CHICAGO'S LINCOLN PARK NEIGHBORHOOD TO THE LOUIS A. SIMPSON & KIMBERLY K. QUERREY BIOMEDICAL RESEARCH BUILDING LOCATED JUST ONE CITY BLOCK FROM LURIE CHILDREN'S ON THE NORTHWESTERN UNIVERSITY CHICAGO CAMPUS IN THE STREETERVILLE NEIGHBORHOOD. THIS NEW TWO-PHASE, 22-STORY BUILDING INCLUDES A WET-BENCH LABORATORY; ANIMAL FACILITY; AND CONFERENCE, EDUCATIONAL, OFFICE AND COLLABORATIVE SPACE; AND IS IMMEDIATELY ADJACENT TO NORTHWESTERN UNIVERSITY RESEARCH RESOURCES. BASIC SCIENCE RESEARCH AT MANNE RESEARCH INSTITUTE, OUR SCIENTISTS CONDUCT BENCH RESEARCH IN LABORATORIES USING A VARIETY OF MODEL SYSTEMS AND TECHNIQUES WITH OVER 50 WET-BASED LABORATORIES. THIS TYPE OF RESEARCH SEEKS TO ANSWER FUNDAMENTAL QUESTIONS ABOUT HEALTH AND DISEASE, INCLUDING MEDICAL CONDITIONS, HUMAN DEVELOPMENT AND GENETICS, SO THAT THE RESULTS WILL LEAD TO BETTER THERAPIES, DEVICES OR CURES FOR PATIENTS. CLINICAL RESEARCH CLINICAL RESEARCH USES BOTH OBSERVATIONAL AND INTERVENTIONAL DESIGNS, ALLOWS DESCRIPTION OF DISEASES AND DISEASE OUTCOMES, IDENTIFIES RISK FACTORS THAT MAY AFFECT TREATMENT OR PROGNOSIS, AND ALLOWS FOR THE STUDY OF NEW TREATMENTS. RESEARCH MAY BE CONDUCTED ONLY AT LURIE CHILDREN'S, OR AT MULTIPLE INSTITUTIONS THAT COLLABORATE, SHARE RESULTS AND PUBLISH FINDINGS TOGETHER. ALL RESEARCH INVOLVING HUMAN SUBJECTS IS REVIEWED BY THE INSTITUTIONAL REVIEW BOARD. OBSERVATIONAL STUDIES MAY USE EXISTING DATA FROM MEDICAL RECORDS, OR COLLECT DATA FROM VOLUNTEERS. STUDIES OF THERAPEUTIC INTERVENTIONS ARE AVAILABLE ON CLINICALTRIALS.GOV, THE LARGEST AND MOST COMPREHENSIVE LIST OF CLINICAL STUDIES BEING CONDUCTED IN THE UNITED STATES. CLINICAL & TRANSLATIONAL RESEARCH IS A PARTNER OF THE NORTHWESTERN UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCES (NUCATS) INSTITUTE, WHICH IS A MEMBER OF THE CLINICAL AND TRANSLATIONAL SCIENCE AWARDS (CTSA) CONSORTIUM, AN INITIATIVE LED BY THE NATIONAL INSTITUTES OF HEALTH (NIH). HEALTH SERVICES AND POLICY RESEARCH THE MARY ANN & J. MILBURN SMITH CHILD HEALTH RESEARCH, OUTREACH AND ADVOCACY CENTER ADDRESSES IMPORTANT CLINICAL AND PUBLIC HEALTH PROBLEMS OF CHILDREN THROUGH STATE-OF-THE-ART INTERDISCIPLINARY METHODS AND COLLABORATIONS. THE CENTER ENGAGES IN CLINICAL, COMMUNITY AND POPULATION-BASED RESEARCH TO ADVANCE KNOWLEDGE ABOUT THE NATURAL HISTORY, BIOLOGICAL, PSYCHOLOGICAL, SOCIAL AND ENVIRONMENTAL CAUSES OF COMMON AND IMPORTANT CHILD HEALTH PROBLEMS. THE CENTER ALSO PARTNERS WITH COMMUNITIES AND POLICY MAKERS TO TRANSLATE THIS KNOWLEDGE INTO EFFECTIVE CLINICAL AND PUBLIC HEALTH INTERVENTIONS AND POLICY. ADDITIONALLY, THE CENTER TRAINS A NEW GENERATION OF CHILD HEALTH PROFESSIONALS AND RESEARCHERS WITH ITS INTERDISCIPLINARY, COLLABORATIVE PUBLIC HEALTH APPROACH TO RESEARCH. STANLEY MANNE CHILDREN'S RESEARCH INSTITUTE RESEARCH NEIGHBORHOODS AND PRIORITY RESEARCH INITIATIVES THE LABORATORY-BASED PROGRAMS OF MANNE RESEARCH INSTITUTE, CENTRALLY LOCATED IN THE NEW SIMPSON-QUERREY BIOMEDICAL RESEARCH CENTER, ARE ORGANIZED INTO SCIENTIFIC NEIGHBORHOODS. THESE VIRTUAL NEIGHBORHOODS INCORPORATE INVESTIGATORS, STAFF AND TRAINEES FROM THROUGHOUT THE RESEARCH INSTITUTE, INCLUDING TRANSLATIONAL, CLINICAL, OUTCOMES, AND PUBLIC HEALTH AND POLICY RESEARCHERS, AS WELL AS EXTERNAL RESEARCH COLLABORATORS. A PRIMARY GOAL OF THE RESEARCH INSTITUTE IS TO FACILITATE RESEARCH LEADING TO THE MOST ADVANCED PEDIATRIC HEALTHCARE. NEIGHBORHOODS *HUMAN MOLECULAR GENETICS *ENGINEERED SOLUTIONS FOR HEALTH AND PHYSIOLOGY *INJURY, REPAIR, AND REGENERATION *MOLECULAR AND TRANSLATIONAL *IMMUNE DEVIATION AND DISEASE CANCER BIOLOGY *PERINATAL ORIGINS OF DISEASE *DEVELOPMENTAL BIOLOGY *HOST-MICROBIAL INTERACTIONS, INFLAMMATION, AND IMMUNITY (HMI3) *NEUROBIOLOGY *FERTILITY AND HORMONE PRESERVATION AND RESTORATION PRIORITY RESEARCH INITIATIVES *PRECISION MEDICINE ENCOMPASSES THE CONCEPT THAT EVERY PATIENT SHOULD BE TREATED BASED UPON THE UNIQUE UNDERLYING CAUSE OF THEIR DISEASE, AND UPON THE UNIQUE BIOLOGIC CHARACTERISTICS THAT DETERMINE BOTH THEIR RESPONSE TO THEIR DISEASE AND TO THE THERAPY PROVIDED. *FERTILITY AND HORMONE PRESERVATION AND RESTORATION FOCUSES ON DEVELOPING IMMEDIATE IMPROVEMENTS IN CLINICAL PRACTICE, ESTABLISHING THE NEXT SET OF TRANSLATIONAL RESEARCH, AND SUPPORTING FUTURE FERTILITY AND ENDOCRINE INNOVATIONS. *PERINATAL ORIGINS OF DISEASE IS AIMED AT PREVENTION OF EARLY CHILDHOOD DISEASES THAT IMPACT LONG-TERM HEALTH OUTCOMES WITH A MULTIDISCIPLINARY PROGRAM, WHICH LINKS CHILDHOOD DISORDERS TO DISRUPTIONS IN THE FETAL ENVIRONMENT, AND A PLATFORM FOR SHIFTING THE PARADIGM FROM TREATMENT OF ESTABLISHED DISEASE TO PRENATAL/FETAL INTERVENTIONS TO MODIFY RISK FACTORS BEFORE THEY MANIFEST. *HOST-MICROBIAL INTERACTIONS, INFLAMMATION AND IMMUNITY (HMI3) TRANSLATES PATIENT-SPECIFIC MICROBIOMICS AND IMMUNOLOGY INTO NOVEL DISEASE DIAGNOSTICS AND THERAPEUTICS. *NEUROSCIENCES AND NEURODEVELOPMENTAL OUTCOMES FOCUSES ON IMPROVING OUTCOMES FOR HIGH-RISK NICU GRADUATES AND COMPLEX HEART DISEASE SURVIVORS WITH BRAIN INJURY AND DISORDERS OF BRAIN DEVELOPMENT. *NEUROSCIENTIFIC ASPECTS OF PAIN FOCUSES ON PILOTING AND INTEGRATION OF PATIENT-REPORTED OUTCOMES (PROS) AND PEDIATRIC PAIN RESEARCH AND CARE. *FOOD ALLERGY IS ENGAGED IN RESEARCH PROJECTS RELATED TO EARLY IMMUNE DEVELOPMENT, COMMUNITY EDUCATION AND TRANSLATIONAL INVESTIGATION OF CHILDHOOD FOOD ALLERGY AND ASTHMA. *GENDER AND SEX DEVELOPMENT CONCENTRATES ON IMPROVING EVIDENCE- BASED CLINICAL CARE FOR THE CLINICAL POPULATIONS SERVED BY OUR GENDER AND SEX DEVELOPMENT PROGRAM: TRANSGENDER AND GENDER-NONCONFORMING CHILDREN, ADOLESCENTS AND YOUNG ADULTS AND YOUTH AFFECTED BY DIFFERENCES OF SEX DEVELOPMENT.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Thomas P Shanley MD Ex-Offc Dir/pres & CEO Lch | OfficerTrustee | 1 | $0 |
Ron Blaustein Chief Financial Officer | Officer | 1 | $0 |
Cassandra L Lucas Chief Admin Officer Ri | Officer | 40 | $0 |
Fatema Zanzi Senior Vp, Chf Legal Officer | Officer | 1 | $0 |
Elizabeth J Perlman MD Ex-Officio Director | Trustee | 1 | $0 |
Marleta Reynolds MD Ex-Officio Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Ascent Pgm Llc Consulting Services | 8/30/20 | $300,865 |
Impact Advisors Llc Consulting Services | 8/30/20 | $351,335 |
Twin Eagle Resource Marketing Services | 8/30/20 | $167,939 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $38,980,940 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $38,980,940 |
Total Program Service Revenue | $46,756 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $39,027,696 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $21,585,414 |
Pension plan accruals and contributions | $1,202,786 |
Other employee benefits | $4,935,504 |
Payroll taxes | $830,743 |
Fees for services: Management | $0 |
Fees for services: Legal | $14,376 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $3,632,861 |
Advertising and promotion | $0 |
Office expenses | $122,491 |
Information technology | $16,243 |
Royalties | $0 |
Occupancy | $3,665,118 |
Travel | $8,064 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $449 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $10,255,335 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $51,005,298 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $660,000 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $348,766 |
Net Land, buildings, and equipment | $168,114,884 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $169,123,650 |
Accounts payable and accrued expenses | $4,940,226 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $4,940,226 |
Net assets without donor restrictions | $164,183,424 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $169,123,650 |
Over the last fiscal year, we have identified 1 grants that Stanley Manne Childrens Research Institute has recieved totaling $9,150.
Awarding Organization | Amount |
---|---|
United Way Of Bergen County Paramus, NJ PURPOSE: DONOR DESIGNATION | $9,150 |
Organization Name | Assets | Revenue |
---|---|---|
Stanley Manne Childrens Research Institute Chicago, IL | $169,123,650 | $39,027,696 |
Morgridge Institute Foundation Inc Madison, WI | $491,309,219 | $74,942,129 |
Walther Cancer Foundation Inc Indianapolis, IN | $153,573,547 | $10,375,494 |
Area Ambulance Authority Cedar Rapids, IA | $10,871,659 | $8,115,144 |
Emily G Plumb Charitable Trust 02-40073 Chicago, IL | $40,196,560 | $2,064,076 |
Allsup Charitable Services Inc Belleville, IL | $56,195 | $1,271,531 |
West Side Institute For Science And Education Chicago, IL | $0 | $965,979 |
International Clinical Cytometry Society Glenview, IL | $947,003 | $624,954 |
National Niemann-Pick Disease Foundation Fort Atkinson, WI | $850,802 | $499,229 |
American Board Of Medical Specialties Research & Education F Chicago, IL | $305,881 | $0 |
Design Industries Foundation Fighting Aids-Chicago Inc Chicago, IL | $1,326,624 | $272,741 |
Familial Dysautonomia Now Foundation Buffalo Grove, IL | $882,138 | $293,462 |